Hongwei Yao Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Chair, Department of GI Surgery

John Brown University

faculty

30 h-index 222 pubs 2,948 cited

Research Areas

Colorectal Cancer Surgical Treatments Colorectal Cancer Screening and Detection Gastric Cancer Management and Outcomes Colorectal and Anal Carcinomas Colorectal Cancer Treatments and Studies Neonatal Respiratory Health Research Chronic Obstructive Pulmonary Disease (COPD) Research Sirtuins and Resveratrol in Medicine

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Dr. Hongwei Yao chairs the Department of GI Surgery at John Brown University, where he conducts research on a broad range of topics. His work encompasses colorectal cancer, from surgical treatments like complete mesocolic excision to screening and detection methods. He is also actively involved in studies of gastric cancer management and outcomes. Yao's research extends beyond gastrointestinal cancers to include neonatal respiratory health, COPD, and the role of sirtuins and resveratrol in medicine, as well as congenital diaphragmatic hernia. His recent publications reflect a strong interest in novel therapeutic approaches, including studies of nano-oxygenated hydrogels for wound healing and the application of neoadjuvant anti-PD-1/PD-L1 therapy for colorectal cancer. He also investigates the opportunities and challenges of nanomaterials in wound healing. Yao's research explores genomics, phytochemicals, and oxidative stress, reflecting a multifaceted approach to disease management.

Metrics

h-index: 30
Publications: 222
Citations: 2,948

Selected Publications

The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives (2025) DOI
Identification of key genes as diagnostic biomarkers for IBD using bioinformatics and machine learning (2025) DOI
The structural basis of TRIM25-mediated regulation of RIG-I (2025) DOI
Human cytomegalovirus UL82 promotes cell cycle progression of colorectal cancer by upregulating AGR2 (2025) DOI
Rectal cancer approach strategies after neoadjuvant treatment – a systematic review and network meta-analysis (2025) DOI
BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma (2025) DOI
Rationale and design of a multicentre randomised controlled trial on circulating tumour DNA-guided neoadjuvant treatment strategy for locally advanced rectal cancer (CINTS-R) (2025) DOI
Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trial (2025) DOI
Predictive model of the surgical difficulty of robot-assisted total mesorectal excision for rectal cancer: a multicenter, retrospective study (2024) DOI
Unraveling the role of gut microbiome in predicting adverse events in neoadjuvant therapy for rectal cancer (2024) DOI
Intracorporeal versus Extracorporeal Anastomosis in Laparoscopic Right Hemicolectomy: An Updated Systematic Review and Meta-Analysis of Randomized Control Trials (2024) DOI
Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC Trial (2024) DOI
Chinese national clinical practice guidelines on prevention, diagnosis and treatment of early colorectal cancer (2024) DOI
Definition and grading of anastomotic leakage following right hemicolectomy (2024) DOI
Opportunities and challenges of nanomaterials in wound healing: Advances, mechanisms, and perspectives (2024) DOI